公司資料
Petros Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- PTPI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年8月17日
—
市值
股價為何變動
As of Aug 17, 2026, PTPI was little changed and closed at $0.0027. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Petros Pharmaceuticals is a specialty pharmaceutical company focused on men’s health and self-care products, including sexual-health-related therapies. Its business is centered on consumer-accessible specialty medicines rather than classic biotech discovery.
所在地與產業分類
Petros is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and men’s health.
商業模式特徵
The company depends on commercial execution, regulatory pathways, and the ability to expand access to a narrow product set. Investors usually watch product adoption, label strategy, and cash management.
生技產業定位
Petros occupies a niche men’s-health specialty-pharma position. It is less about clinical-stage binary risk and more about commercial access and brand execution.
未來催化劑
- Petros’s catalysts are men’s-health and sexual-health commercialization, plus any strategic update that clarifies the company’s future. The market will care about whether the product base can stabilize.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。